Phase I trial of orally administered R 348 in male volunteers.
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2012
At a glance
- Drugs R 348 (Primary)
- Indications Autoimmune disorders; Graft-versus-host disease; Psoriasis; Rheumatoid arthritis; Transplant rejection
- Focus Adverse reactions; Pharmacokinetics
- 17 Jan 2008 New trial record.